# FDA recall D-1344-2014

> **SigmaPharm Laboratories LLC** · Class II · drug recall initiated 2014-04-22.

## Product

Liothyronine Sodium Tablets, USP 5 mcg, Rx Only, a) 100-count bottle NDC 42794-018-02 and b) 1000-count bottle NDC 42794-018-06, SigmaPharm Laboratories, LLC, Bensalem, Pa.

## Reason for recall

Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a potential carryover of trace amounts of a previously manufactured product.

## Distribution

Nationwide and Puerto Rico

## Key facts

- **Recall number:** D-1344-2014
- **Recalling firm:** SigmaPharm Laboratories LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-04-22
- **Report date:** 2014-05-28
- **Termination date:** 2015-03-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Bensalem, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1344-2014

## Citation

> AI Analytics. FDA recall D-1344-2014. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-1344-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*